YOLK SAC TUMOR
Clinical trials for YOLK SAC TUMOR explained in plain language.
Never miss a new study
Get alerted when new YOLK SAC TUMOR trials appear
Sign up with your email to follow new studies for YOLK SAC TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Supercharged t cells take on hard-to-treat cancers in new trial
Disease control Recruiting nowThis early-phase study tests a new type of immunotherapy for adults with solid tumors that have a specific marker called GPC3. The treatment involves taking a patient's own T cells, adding genes to help them recognize and attack cancer cells, and then giving them back. The study …
Matched conditions: YOLK SAC TUMOR
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 17, 2026 00:46 UTC
-
New hope for rare cancers: immunotherapy trial targets tumors regardless of origin
Disease control Recruiting nowThis study tests the drug nivolumab in people with advanced rare cancers that have a specific marker (PD-L1). The goal is to see if the drug can shrink or control tumors for at least 12 months. About 28 adults who have not responded to standard treatments will take part.
Matched conditions: YOLK SAC TUMOR
Phase: PHASE2 • Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Disease control
Last updated May 17, 2026 00:30 UTC
-
New CAR t therapy targets Hard-to-Treat childhood cancers
Disease control Recruiting nowThis early-stage trial tests a new type of immunotherapy for children and young adults with certain solid tumors that have come back or not responded to treatment. The therapy uses the patient's own immune cells, which are modified in a lab to better recognize and attack cancer c…
Matched conditions: YOLK SAC TUMOR
Phase: PHASE1 • Sponsor: Seattle Children's Hospital • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
Engineered immune cells take on childhood cancers in new trial
Disease control Recruiting nowThis early-phase trial tests a new experimental treatment called CARE T cells for children and young adults with certain solid tumors (like liver cancer or Wilms tumor) that have returned or not responded to standard therapy. The treatment involves taking a patient's own immune c…
Matched conditions: YOLK SAC TUMOR
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 12, 2026 13:39 UTC
-
Massive study aims to unlock secrets of childhood germ cell tumors
Knowledge-focused Recruiting nowThis study follows over 1,100 children and teens diagnosed with germ cell tumors to learn about short- and long-term side effects from treatment, like hearing loss. Researchers will also analyze tumor DNA and other markers to better predict which patients might have their cancer …
Matched conditions: YOLK SAC TUMOR
Sponsor: Children's Oncology Group • Aim: Knowledge-focused
Last updated May 17, 2026 00:47 UTC